ADMA Biologics, Inc.

ADMA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$103,147$51,352$86,522$51,089
Short-Term Investments$0$0$0$0
Receivables$49,999$27,421$15,505$28,577
Inventory$170,235$172,906$163,280$124,724
Other Curr. Assets$8,029$5,334$5,095$4,339
Total Curr. Assets$331,410$257,013$270,402$208,729
Property Plant & Equip (Net)$63,341$63,470$68,746$58,198
Goodwill$3,530$3,530$3,530$3,530
Intangibles$460$499$1,013$1,729
Long-Term Investments$0$0$0$0
Tax Assets$84,280$0$0$0
Other NC Assets$5,657$4,670$4,770$4,067
Total NC Assets$157,268$72,169$78,059$67,523
Other Assets$0$0$0$0
Total Assets$488,678$329,182$348,461$276,253
Liabilities
Payables$20,219$15,660$13,229$12,429
Short-Term Debt$1,218$1,045$905$591
Tax Payable$3,481$0$0$0
Deferred Revenue$143$182$143$143
Other Curr. Liab.$30,481$32,919$24,990$17,215
Total Curr. Liab.$55,542$49,806$39,267$30,378
LT Debt$80,898$140,373$153,537$102,329
Deferred Rev, NC$1,547$1,690$1,833$1,976
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,673$2,107$1,850$397
Total NC Liab.$84,118$144,170$157,220$104,702
Other Liabilities$0$0$0$0
Cap. Leases$9,779$10,824$11,609$8,053
Total Liabilities$139,660$193,976$196,487$135,080
Equity
Pref Stock$0$0$0$0
Common Stock$24$23$22$20
Retained Earnings-$308,583-$506,256-$478,017-$412,113
AOCI$0$0$0$0
Other Equity$657,577$641,439$629,969$553,266
Total Equity$349,018$135,206$151,974$141,173
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$488,678$329,182$348,461$276,253
Net Debt-$21,031$90,066$67,920$51,831